QURE
Uniqure NV
NASDAQ: QURE · HEALTHCARE · BIOTECHNOLOGY
$16.73
-7.31% today
Updated 2026-04-29
Market cap
$1.05B
P/E ratio
—
P/S ratio
65.51x
EPS (TTM)
$-3.46
Dividend yield
—
52W range
$9 – $72
Volume
3.4M
Uniqure NV (QURE) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-901.00%
ROE
-207.10%
ROA
-16.20%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2011 | — | $-22.42M | — | — | — |
| 2012 | — | $-19.46M | — | — | — |
| 2013 | $4.06M | $-37.03M | 72.82% | -765.72% | -911.32% |
| 2014 | $5.70M | $-45.04M | -664.91% | -722.18% | -790.61% |
| 2015 | $10.30M | $-78.15M | 93.80% | -726.12% | -758.41% |
| 2016 | $25.10M | $-73.37M | 100.00% | -286.66% | -292.35% |
| 2017 | $13.11M | $-80.39M | -414.30% | -549.00% | -613.33% |
| 2018 | $11.28M | $-83.30M | -547.47% | -781.92% | -738.25% |
| 2019 | $7.28M | $-124.20M | 100.00% | -1,663.78% | -1,705.82% |
| 2020 | $37.51M | $-125.02M | -226.28% | -334.34% | -333.27% |
| 2021 | $524.00M | $329.59M | 95.23% | 59.28% | 62.90% |
| 2022 | $106.48M | $-126.79M | 96.86% | -134.44% | -119.07% |
| 2023 | $15.84M | $-308.48M | 13.98% | -1,785.46% | -1,947.09% |
| 2024 | $27.12M | $-239.56M | 32.42% | -679.58% | -883.35% |
| 2025 | $16.10M | $-198.97M | -2.16% | -1,152.13% | -1,236.00% |